US govt sets lower premiums for Medicare Advantage and prescription drug plans in 2023

In the USA, the Biden-Harris Administration announced yesterday that it has made expanding access to health insurance and lowering health care costs for America’s families a top priority.

The administration is announcing that people with Medicare will see lower premiums for Medicare Advantage and Medicare Part D prescription drug plans in 2023.

Additionally, due to the Inflation Reduction Act, people with Medicare prescription drug coverage will have improved and more affordable benefits, including a $35 cost-sharing limit on a month’s supply of each covered insulin product, as well as adult vaccines that are recommended by the Advisory Committee on Immunization Practices (ACIP) at no additional cost.